Skip to content

A study to compare tablet and paste form of turmeric to treat gum infection.

Comparative evaluation of different formulations of nano-curcumin for the treatment of gingivitis: A randomized controlled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059242
Enrollment
60
Registered
2023-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: Nanocurcumin 30 mg capsule- SNEC30: Oral Nano-curcumin 30 mg capsule which is available in the market is used in this trial. (SNEC 30) Patients recruited will consume the capsule once p
for 14 days, Oral Nano-curcumin 30 mg OD for 14 days. Intervention2: Nanocurcumin gel purchased SNEC-G oral gel: Nanocurcumin gel- SNEC-G oral gel. A pea size gel needs to massage on the gums once

Sponsors

Dr Ananya Prabhu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with signs of generalized plaque-induced gingivitis. 2. Patient having at least 20 teeth

Exclusion criteria

Exclusion criteria: 1. Patients with some systemic disease; 2. Patients undergoing treatment for periodontal disease; 3. Individuals who have used broad-spectrum antibiotics within the last 3 months.; 4. Individuals who have used an antimicrobial mouth rinse within the last two weeks.; 5. Pregnant women; 6. Patients who are allergic to turmeric; 7. Patients with a history of gallstone and/or biliary obstruction

Design outcomes

Primary

MeasureTime frame
Plaque index (PI), modified gingival index (MGI),Timepoint: Baseline, Day 7 and Day 14

Secondary

MeasureTime frame
papillary bleeding index (PBI)Timepoint: Baseline, Day 7 and Day 14

Countries

India

Contacts

Public ContactDr Deepak Singhal

Manipal Academy of Higher Education

dk.singhal@manipal.edu9379060983

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026